Related Experiment Video
Updated: Jul 8, 2026
06:02
Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Flagellate erythema induced by docetaxel
1Department of Dermatology, Auckland District Health Board, New Zealand. bentallon@gmail.com
Clinical and Experimental Dermatology
|January 19, 2008
Summary
Flagellate erythema, a rare skin reaction, can occur after docetaxel chemotherapy. This case highlights docetaxel as a potential cause, suggesting oral corticosteroids may help prevent this reaction.
Area of Science:
- Oncology
- Dermatology
Background:
- Docetaxel is a widely used taxane chemotherapy agent.
- Chemotherapy infusions, particularly docetaxel, are frequently associated with cutaneous adverse events, affecting up to 70% of patients.
Observation:
- This report details a case of flagellate erythema, a distinctive whip-like rash, occurring in a patient undergoing docetaxel treatment.
- Flagellate erythema is a known side effect of certain chemotherapy drugs, such as bleomycin and peplomycin.
Findings:
- This is the first documented instance of docetaxel-induced flagellate erythema.
- The findings suggest that docetaxel should be recognized as a potential cause of flagellate erythema.
Implications:
- This case expands the differential diagnosis for flagellate erythema in patients receiving chemotherapy.
- Early recognition and potential prophylactic treatment with oral corticosteroids may mitigate the occurrence or severity of this docetaxel-induced skin reaction.
